Download PDF
1 / Pages

Other users also viewed these articles

Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction Elaine Monteiro Matsuda; Ivana Barros Campos; Isabela Penteriche de Oliveira; Daniela Rodrigues Colpas; Giselle Ibete Silva López-Lopes; Victor Oliveira Chiavegato; Luís Fernando de Macedo Brígido;
Braz J Infect Dis. 2023;27:
Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials Elahe Akbari; Masoud Seyedinkhorasani; Azam Bolhassani;
Braz J Infect Dis. 2023;27:
Human monkeypox preparedness in Latin America ¿ Are we ready for the next viral zoonotic disease outbreak after COVID-19? Sergio Cimerman; Alberto Chebabo; Clovis Arns da Cunha; Alexandre Naime Barbosa; Alfonso J. Rodríguez-Morales;
Braz J Infect Dis. 2022;26: